Media
Phage Australia - registration success
We are thrilled to announce that Phage Australia - a division of the Westmead Institute has been registered by INTERTEK SAI Global as conforming to the requirements of: ISO 9001:2015. The management system is applicable to: the provision of biobanking, genomics, development, production, distribution and monitoring of therapeutic phages. This prestigious certification reflects our commitment to maintaining the highest quality standards in the development and production of phage therapies.
ISO 9001 certification not only enhances our operational efficiency but also ensures that our products meet the rigorous safety and quality requirements essential for advancing public health. We are dedicated to pioneering innovative solutions in phage therapy, and this certification marks a significant milestone in our journey. Thank you to our dedicated team for their hard work and commitment.
Ruby Lin, July 2025
Phage therapy holds promise for combating AMR
As antimicrobial resistance (AMR) increases, phage therapy offers promise not only as a treatment for antibiotic-resistant infections, but also as a potential alternative to antibiotics themselves.
Bianca Nogrady, AMR Action Insights, June 2025 - Read the article
